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Between October 2012 and May 2013, five cases of 
invasive meningococcal disease in young men who 
have sex with men (MSM) living in Berlin were notified 
to local health authorities in Germany. Three of the five 
cases died. All were caused by serogroup C variants 
with the finetype P1.5-1,10-8:F3-6. Awareness was 
increased through the use of community networks; an 
extension of the existing vaccination recommendation 
to all MSM is currently being considered.
As of 2 July 2013, 208 cases of invasive meningococ-
cal disease (IMD) were reported in Germany since the 
beginning of the year, which is similar to previous 
years (2012: 189 cases; 2011: 224 cases). Among the 
cases reported from Berlin (n=17) were three cases of 
IMD due to MenC in young men who have sex with men 
(MSM). 
IMD is a rare but serious disease caused by Neisseria 
meningitidis, a gram-negative, encapsulated diplococ-
cus. The clinical spectrum of IMD is diverse and may 
vary from a mild febrile illness to septicaemia and/or 
meningitis, which may progress to fulminant disease, 
multi-organ failure and death within hours [1]. The 
proportion of patients who develop severe disease 
increases with age [2]. 
Twelve distinguishable serogroups have been 
described [3]. N. meningitidis serogroups B (MenB) and 
C (MenC) predominate in Germany and affect mainly 
young children and adolescents [4]. Annual IMD inci-
dence in Germany was 0.45 per 100,000 in the years 
2010 to 2012 (n=386, n=369, n=354) [5]. Among young 
adults aged 20–29 years, IMD incidence in 2010 to 
2012 was 0.65 per 100,000. Case fatality in 2012 was 
9.3% and was highest in patients with MenC (13%) [5]. 
In 2006, the German Standing Committee on 
Vaccination (STIKO) recommended routine MenC 
vaccination in the second year of life. Catch-up vacci-
nation for all children and adolescents under the age of 
18 years on an individual basis is recommended, but a 
catch-up campaign was not undertaken. In 2010, MenC 
vaccination coverage at school entry ranged between 
53% and 90% in the 16 German federal states [4]. In 
addition to routine childhood vaccination, STIKO rec-
ommends vaccination against serogroups A, C, W135 
and Y for high-risk individuals independent of their 
age (i.e. patients with asplenia or immunocompro-
mised individuals including those infected with human 
immunodeficiency virus (HIV)). However, meningococ-
cal vaccine coverage among HIV patients in Germany 
is unknown. Vaccines are free of charge in Germany if 
officially recommended, but can otherwise be individu-
ally purchased if prescribed by a physician. 
Description of cases  
Case 1 was a man in his early 20s. He developed chills, 
fever and severe abdominal pain in early February, was 
hospitalised, and died during abdominal surgery within 
10 hours after hospital admission. MenC was found in 
blood culture. The patient had visited several gay ven-
ues in Berlin in the days before falling ill. Cases 2 and 
3 were both in their mid-20s. They visited a gay night-
club in May and spent the following night together. Two 
days later, Case 2 developed symptoms (fever, nausea, 
vomiting, irritability, stiff neck), was hospitalised, and 
treated in an intensive care unit. He survived, but suf-
fers from irreversible brain damage. Case 3 developed 
symptoms a day later (irritability, fever, nausea), but 
did not seek medical care and died at home on the 
following day. An autopsy revealed death due to sep-
tic shock and disseminated intravascular coagulation. 
MenC was detected in cerebrospinal fluid.
Besides smoking (two cases) and attending gay bars, 
no other risk factors were reported. None of the three 
young men had been diagnosed with HIV, and none of 
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the three was vaccinated against MenC. While a com-
mon source or direct transmission between Cases 2 
and 3 seems likely, no direct link between Case 1 and 
Cases 2 and 3 was found. No links to men who visited 
or lived in cities with concurrent or recent IMD out-
breaks among MSM (e.g. Paris or New York) could be 
established [6,7].  
Molecular typing
All three infections were due to N. meningitidis sero-
group C: PorA-VR1 5-1, PorA-VR2 10-8: FetA F3-6 (C:P1.5-
1,10-8:F3-6) and confirmed as sequence type (ST) 11. 
Analysis of position 640 of the fumC gene revealed that 
the strains belonged to a subclone of ST-11 designated 
electrophoretic type (ET) 15, which has caused a num-
ber of small outbreaks in Germany since 1998 [8]. The 
PorA and FetA variants are classically linked to ET-15 
and the combination C:P1.5-1,10-8:F3-6 is observed 
frequently. Therefore, three further typing loci were 
included, i.e. porB, fHbp, and penA. All three isolates 
were identical also with regard to these markers: porB 
allele 2-2, fHbp allele 766, and penA allele 3. This find-
ing supports the hypothesis of a local cluster and link 
between the three cases. 
Retrospective epidemiology
In an analysis of data from the German disease noti-
fication system restricted to IMD cases aged 15 to 49 
years occurring in the five largest metropolitan areas 
(i.e. Berlin, Hamburg, Munich, Cologne and Frankfurt), 
we identified in total n=15, n=11, n=14 and n=20 
reported IMD cases in calendar weeks 1 to 27 for 2010, 
2011, 2012 and 2013, respectively. In these five areas, 
the proportion of males with IMD in this specific age-
group ranged between 40% and 54% in the period 2010 
to 2012, whereas this proportion was 80% in 2013. In 
contrast, the sex distribution remained similar over the 
years when the analysis was not restricted to the five 
metropolitan areas (57%, 58%, 62% and 61% males, 
respectively). 
When the local health authorities in Berlin became 
aware of this potential IMD outbreak among MSM, 
they investigated retrospectively if any of the other 
invasive MenC cases in young men notified in 2012–13 
were MSM. Two additional cases were identified. One 
case was notified in February 2013, the other case in 
October 2012, both were in their late 20s. The latter 
case had developed signs of sepsis and died. Isolates 
from both cases had been characterised at the German 
Reference Laboratory for Meningococci as the same 
finetype PorA-VR1:5-1; PorA-VR2:10-8 and FetA:3-6. As 
the isolates were still available, further genetic typing 
was possible. Complementary typing has to date only 
been conducted for one isolate. The strain obtained 
from the case notified in February 2013 differed from 
the variant found in the series of Cases 1–3 with regard 
to the penA allele (penA-2) and the fhbp allele (new 
variant). This finding suggests that at least this case 
was caused by a highly related, yet distinct variant and 
that more than one strain was involved in this cluster 
of five cases.
Public health response
From October 2012 until the end of June 2013, the inci-
dence of MenC IMD among the MSM community in 
Berlin was 6.3/100,000 based on five reported cases 
and an estimated number of 80,000 MSM in the com-
munity [9]. This is below the threshold of an epidemic 
situation (defined in Germany as ≥10 cases/100,000 in 
a given region within three months), but almost 10-fold 
higher than expected for young male adults in this age 
group for the entire year (0.65/100,000 with inclusion 
of all serogroups). 
Infectious disease surveillance networks in Germany 
and healthcare professionals in Berlin were alerted 
to the detection of this IMD cluster among MSM, 
which will help to identify additional cases rapidly if 
they occur. The German AIDS support organisation 
Deutsche AIDS Hilfe has issued information on the 
cluster on their website as a first measure to inform 
the MSM community about symptoms of the disease 
and the existing recommendation to vaccinate HIV-
positive individuals against IMD. According to STIKO, 
the existing meningococcal vaccination recommenda-
tion targeting risk groups (such as HIV patients) can be 
extended to other population subgroups by the respon-
sible health authorities during regional outbreaks, 
taking into account the epidemiological and temporal 
associations between notified cases [10]. Since no HIV 
patients have been identified in the MSM cluster as of 
today, the state health authority in Berlin is currently 
considering the option of extending the existing vac-
cination recommendation to all MSM to prevent further 
cases.
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